Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical models.
Chang TY, Yan Y, Yu ZY, Rathore M, Lee NZ, Tseng HJ, Cheng LH, Huang WJ, Zhang W, Chan ER, Qing Y, Kang ML, Wang R, Tsai KK, Pink JJ, Harte WE, Gerson SL, Lee SB.
Chang TY, et al.
J Clin Invest. 2024 Oct 22;134(23):e165448. doi: 10.1172/JCI165448. Online ahead of print.
J Clin Invest. 2024.
PMID: 39436709
Free PMC article.